{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:56:12Z","timestamp":1790553372938,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nature Science Foundation of Chongqing","award":["stc2021cyj-msxmX064"],"award-info":[{"award-number":["stc2021cyj-msxmX064"]}]},{"name":"Young Doctor Research project of the Second Affiliated Hospital of Army Medical University","award":["2024YQB044"],"award-info":[{"award-number":["2024YQB044"]}]},{"name":"Chongqing Key Specialty Construction Project of Clinical Pharmacy","award":["[2023]69"],"award-info":[{"award-number":["[2023]69"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04749-9","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:07:13Z","timestamp":1783098433000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Artesunate-based macromolecular therapy attenuates neutrophilic asthma by targeting the BCAT1\/Succinate\/NLRP3 metabolite-immunity cascade"],"prefix":"10.1186","volume":"24","author":[{"given":"Jing","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4386-3866","authenticated-orcid":false,"given":"Jingbin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"4749_CR1","unstructured":"Global strategy for asthma management and prevention. 2025. Updated November 2025. Available from: www.ginaasthma.org"},{"issue":"5","key":"4749_CR2","doi-asserted-by":"publisher","first-page":"2102583","DOI":"10.1183\/13993003.02583-2021","volume":"60","author":"D Thomas","year":"2022","unstructured":"Thomas D, McDonald VM, Pavord ID, et al. Asthma remission: what is it and how can it be achieved? Eur Respir J. 2022;60(5):2102583.","journal-title":"Eur Respir J"},{"issue":"1","key":"4749_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2015.25","volume":"1","author":"ST Holgate","year":"2015","unstructured":"Holgate ST, Wenzel S, Postma DS, et al. Asthma. Nat Rev Dis Primers. 2015;1(1):1\u201322.","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"4749_CR4","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.it.2017.07.003","volume":"38","author":"A Ray","year":"2017","unstructured":"Ray A, Kolls JK. Neutrophilic inflammation in asthma and association with disease severity. Trends Immunol. 2017;38(12):942\u201354.","journal-title":"Trends Immunol"},{"key":"4749_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.coi.2018.05.006","volume":"54","author":"C Radermecker","year":"2018","unstructured":"Radermecker C, Louis R, Bureau F, et al. Role of neutrophils in allergic asthma. Curr Opin Immunol. 2018;54:28\u201334.","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"4749_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12931-020-01438-5","volume":"21","author":"J Zhang","year":"2020","unstructured":"Zhang J, Zhu Z, Zuo X, et al. The role of NTHi colonization and infection in the pathogenesis of neutrophilic asthma. Respir Res. 2020;21(1):170.","journal-title":"Respir Res"},{"key":"4749_CR7","doi-asserted-by":"publisher","first-page":"114292","DOI":"10.1016\/j.bcp.2020.114292","volume":"182","author":"J De Volder","year":"2020","unstructured":"De Volder J, Vereecke L, Joos G, et al. Targeting neutrophils in asthma: A therapeutic opportunity? Biochem Pharmacol. 2020;182:114292.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"4749_CR8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/imr.12543","volume":"278","author":"PM Hansbro","year":"2017","unstructured":"Hansbro PM, Kim RY, Starkey MR, et al. Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma. Immunol Rev. 2017;278(1):41\u201362.","journal-title":"Immunol Rev"},{"issue":"14","key":"4749_CR9","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1097\/CM9.0000000000003608","volume":"138","author":"L Zhou","year":"2025","unstructured":"Zhou L, Zhang H, Liu L, et al. Intermittent hypoxia aggravates asthma inflammation via NLRP3\/IL-1\u03b2-dependent pyroptosis mediated by HIF-1\u03b1 signalling pathway. Chin Med J (Engl). 2025;138(14):1714\u201329.","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"4749_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12931-023-02550-y","volume":"24","author":"L Liu","year":"2023","unstructured":"Liu L, Zhou L, Wang L, et al. MUC1 attenuates neutrophilic airway inflammation in asthma by reducing NLRP3 inflammasome-mediated pyroptosis through the inhibition of the TLR4\/MyD88\/NF-\u03baB pathway. Respir Res. 2023;24(1):255.","journal-title":"Respir Res"},{"issue":"4","key":"4749_CR11","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1183\/09031936.00105013","volume":"43","author":"JL Simpson","year":"2014","unstructured":"Simpson JL, Phipps S, Baines KJ, et al. Elevated expression of the NLRP3 inflammasome in neutrophilic asthma. Eur Respir J. 2014;43(4):1067\u201376.","journal-title":"Eur Respir J"},{"issue":"4","key":"4749_CR12","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jaci.2013.12.1091","volume":"133","author":"KJ Baines","year":"2014","unstructured":"Baines KJ, Simpson JL, Wood LG, et al. Sputum gene expression signature of 6 biomarkers discriminates asthma inflammatory phenotypes. J Allergy Clin Immunol. 2014;133(4):997\u20131007.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"4749_CR13","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","volume":"140","author":"K Schroder","year":"2010","unstructured":"Schroder K, Tschopp J. The inflammasomes. Cell. 2010;140(6):821\u201332.","journal-title":"Cell"},{"issue":"4","key":"4749_CR14","doi-asserted-by":"publisher","first-page":"393","DOI":"10.4168\/aair.2022.14.4.393","volume":"14","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhang X, Zhang L, et al. Sputum metabolomic profiling reveals metabolic pathways and signatures associated with inflammatory phenotypes in patients with asthma. Allergy Asthma Immunol Res. 2022;14(4):393\u2013411.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"6","key":"4749_CR15","doi-asserted-by":"publisher","first-page":"2301752","DOI":"10.1183\/13993003.01752-2023","volume":"64","author":"A Aili","year":"2024","unstructured":"Aili A, Wang Y, Shang Y, et al. LPG 18:0 is a general biomarker of asthma and inhibits the differentiation and function of regulatory T-cells. Eur Respir J. 2024;64(6):2301752.","journal-title":"Eur Respir J"},{"issue":"4","key":"4749_CR16","doi-asserted-by":"publisher","first-page":"046015","DOI":"10.1088\/1752-7163\/aade13","volume":"12","author":"M Bazzano","year":"2018","unstructured":"Bazzano M, Laghi L, Zhu C, et al. Metabolomics of tracheal wash samples and exhaled breath condensates in healthy horses and horses affected by equine asthma. J Breath Res. 2018;12(4):046015.","journal-title":"J Breath Res"},{"issue":"2","key":"4749_CR17","doi-asserted-by":"publisher","first-page":"e13856","DOI":"10.1111\/obr.13856","volume":"26","author":"S Mansoori","year":"2025","unstructured":"Mansoori S, Ho MY, Ng KK, et al. Branched-chain amino acid metabolism: Pathophysiological mechanism and therapeutic intervention in metabolic diseases. Obes Rev. 2025;26(2):e13856.","journal-title":"Obes Rev"},{"issue":"4","key":"4749_CR18","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.cell.2018.07.030","volume":"174","author":"MP Murphy","year":"2018","unstructured":"Murphy MP, O\u2019Neill LAJ. Krebs cycle reimagined: the emerging roles of succinate and itaconate as signal transducers. Cell. 2018;174(4):780\u20134.","journal-title":"Cell"},{"key":"4749_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1146\/annurev-immunol-081619-104850","volume":"38","author":"DG Ryan","year":"2020","unstructured":"Ryan DG, O\u2019Neill LAJ. Krebs cycle reborn in macrophage immunometabolism. Annu Rev Immunol. 2020;38:289\u2013313.","journal-title":"Annu Rev Immunol"},{"key":"4749_CR20","doi-asserted-by":"publisher","first-page":"e83064","DOI":"10.7554\/eLife.83064","volume":"12","author":"I Mateska","year":"2023","unstructured":"Mateska I, Witt A, Hagag E, et al. Succinate mediates inflammation-induced adrenocortical dysfunction. Elife. 2023;12:e83064.","journal-title":"Elife"},{"key":"4749_CR21","doi-asserted-by":"publisher","first-page":"103576","DOI":"10.1016\/j.redox.2025.103576","volume":"81","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Gong H, Jin L, et al. Succinate predisposes mice to atrial fibrillation by impairing mitochondrial function via SUCNR1\/AMPK axis. Redox Biol. 2025;81:103576.","journal-title":"Redox Biol"},{"issue":"7444","key":"4749_CR22","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill GM, Curtis AM, Adamik J, et al. Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature. 2013;496(7444):238\u201342.","journal-title":"Nature"},{"issue":"8","key":"4749_CR23","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","volume":"9","author":"HR Keir","year":"2021","unstructured":"Keir HR, Shoemark A, Dicker AJ, et al. Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study. Lancet Respir Med. 2021;9(8):873\u201384.","journal-title":"Lancet Respir Med"},{"key":"4749_CR24","doi-asserted-by":"crossref","unstructured":"Gibson PG, Foster PS. Neutrophilic asthma: welcome back! Eur Respir J. 2019;54(5):1901846.","DOI":"10.1183\/13993003.01846-2019"},{"issue":"3","key":"4749_CR25","first-page":"CD012406","volume":"3","author":"C Kelly","year":"2018","unstructured":"Kelly C, Chalmers JD, Crossingham I, et al. Macrolide antibiotics for bronchiectasis. Cochrane Database Syst Rev. 2018;3(3):CD012406.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"4749_CR26","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S2213-2600(16)30227-2","volume":"4","author":"PM O\u2019Byrne","year":"2016","unstructured":"O\u2019Byrne PM, Metev H, Puu M, et al. Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2016;4(10):797\u2013806.","journal-title":"Lancet Respir Med"},{"issue":"10","key":"4749_CR27","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.cgh.2016.04.039","volume":"14","author":"S Bonovas","year":"2016","unstructured":"Bonovas S, Fiorino G, Allocca M, et al. Biologic therapies and risk of Infection and malignancy in patients with Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis. Clin Gastroenterol Hepatol. 2016;14(10):1385\u2013e139710.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"4749_CR28","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1016\/j.cgh.2021.02.032","volume":"20","author":"S Singh","year":"2022","unstructured":"Singh S, Heien HC, Herrin J, et al. Comparative risk of serious infections with tumor necrosis factor \u03b1 antagonists vs vedolizumab in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2022;20(2):e74\u201388.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4749_CR29","first-page":"12","volume":"28","author":"J Cai","year":"2023","unstructured":"Cai J, Tao H, Liu H, et al. Intrinsically bioactive and biomimetic nanoparticle-derived therapies alleviate asthma by regulating multiple pathological cells. Bioact Mater. 2023;28:12\u201326.","journal-title":"Bioact Mater"},{"issue":"4","key":"4749_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S2468-1253(22)00427-7","volume":"8","author":"BG Feagan","year":"2023","unstructured":"Feagan BG, Sands BE, Sandborn WJ, et al. Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial. Lancet Gastroenterol Hepatol. 2023;8(4):307\u201320.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"4749_CR31","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1038\/s41401-023-01054-1","volume":"44","author":"HY Wang","year":"2023","unstructured":"Wang HY, Lin X, Huang GG, et al. Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases. Acta Pharmacol Sin. 2023;44(8):1687\u2013700.","journal-title":"Acta Pharmacol Sin"},{"key":"4749_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fimmu.2019.00047","volume":"10","author":"M Uddin","year":"2019","unstructured":"Uddin M, Watz H, Malmgren A, Pedersen F. NETopathic inflammation in chronic obstructive pulmonary disease and severe asthma. Front Immunol. 2019;10:47.","journal-title":"Front Immunol"},{"issue":"3","key":"4749_CR33","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1056\/NEJMc081180","volume":"359","author":"PM Arguin","year":"2008","unstructured":"Arguin PM, Weina PJ, Dougherty CP. Artesunate for malaria. N Engl J Med. 2008;359(3):313.","journal-title":"N Engl J Med"},{"key":"4749_CR34","doi-asserted-by":"publisher","first-page":"107526","DOI":"10.1016\/j.phrs.2024.107526","volume":"210","author":"X Liu","year":"2024","unstructured":"Liu X, Cai Y, Zhang Y, et al. Artesunate: A potential drug for the prevention and treatment from hepatitis to hepatocellular carcinoma. Pharmacol Res. 2024;210:107526.","journal-title":"Pharmacol Res"},{"key":"4749_CR35","doi-asserted-by":"publisher","first-page":"1097206","DOI":"10.3389\/fphar.2023.1097206","volume":"14","author":"Q Jin","year":"2023","unstructured":"Jin Q, Liu T, Chen D, et al. Therapeutic potential of artemisinin and its derivatives in managing kidney diseases. Front Pharmacol. 2023;14:1097206.","journal-title":"Front Pharmacol"},{"issue":"25","key":"4749_CR36","doi-asserted-by":"publisher","first-page":"7143","DOI":"10.1016\/j.cell.2024.09.034","volume":"187","author":"H Zhang","year":"2024","unstructured":"Zhang H, Thai PN, Shivnaraine RV, et al. Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target. Cell. 2024;187(25):7143\u2013e716322.","journal-title":"Cell"},{"key":"4749_CR37","doi-asserted-by":"crossref","unstructured":"He Xling, Chen Jyun, Feng Y et al. lin,. Single-cell RNA sequencing deciphers the mechanism of sepsis-induced liver injury and the therapeutic effects of artesunate. Acta Pharmacol Sin. 2023;44(9):1801\u20131814.","DOI":"10.1038\/s41401-023-01065-y"},{"key":"4749_CR38","doi-asserted-by":"publisher","first-page":"1145188","DOI":"10.3389\/fphar.2023.1145188","volume":"14","author":"M Zhang","year":"2023","unstructured":"Zhang M, Lin J, Zhang J, et al. Artesunate inhibits airway remodeling in asthma via the MAPK signaling pathway. Front Pharmacol. 2023;14:1145188.","journal-title":"Front Pharmacol"},{"issue":"2","key":"4749_CR39","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.intimp.2015.11.016","volume":"29","author":"Q Luo","year":"2015","unstructured":"Luo Q, Lin J, Zhang L, et al. The anti-malaria drug artesunate inhibits cigarette smoke and ovalbumin concurrent exposure-induced airway inflammation and might reverse glucocorticoid insensitivity. Int Immunopharmacol. 2015;29(2):235\u201345.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4749_CR40","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1128\/AAC.45.1.181-186.2001","volume":"45","author":"TME Davis","year":"2001","unstructured":"Davis TME, Phuong HL, Ilett KF, et al. Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria. Antimicrob Agents Chemother. 2001;45(1):181\u20136.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"4749_CR41","doi-asserted-by":"publisher","first-page":"e02223","DOI":"10.1128\/AAC.02223-20","volume":"65","author":"C Fanello","year":"2021","unstructured":"Fanello C, Hoglund RM, Lee SJ, et al. Pharmacokinetic study of rectal artesunate in children with severe malaria in Africa. Antimicrob Agents Chemother. 2021;65(4):e02223\u201320.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"4749_CR42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11095-019-2587-6","volume":"36","author":"G Zhao","year":"2019","unstructured":"Zhao G, Wei X, Wu J, et al. A Macromolecular Janus kinase (JAK) inhibitor prodrug effectively ameliorates dextran sulfate sodium-induced ulcerative colitis in mice. Pharm Res. 2019;36(4):64.","journal-title":"Pharm Res"},{"key":"4749_CR43","doi-asserted-by":"publisher","unstructured":"Zhou M, Wang Y, Yang B et al. Engineering a macromolecular JAK inhibitor for treating acute inflammation and endotoxaemia. Nat Biomed Eng. 2025. Online ahead of print. PMID: 41107521 https:\/\/doi.org\/10.1038\/s41551-025-01521-6.","DOI":"10.1038\/s41551-025-01521-6"},{"key":"4749_CR44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.addr.2020.07.010","volume":"157","author":"R Brusini","year":"2020","unstructured":"Brusini R, Varna M, Couvreur P. Advanced nanomedicines for the treatment of inflammatory diseases. Adv Drug Deliv Rev. 2020;157:161\u201378.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"4749_CR45","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1378\/chest.12-1944","volume":"144","author":"CL Grainge","year":"2013","unstructured":"Grainge CL, Davies DE. Epithelial injury and repair in airways diseases. Chest. 2013;144(6):1906\u201312.","journal-title":"Chest"},{"issue":"1","key":"4749_CR46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12951-025-03921-x","volume":"24","author":"Y Hou","year":"2025","unstructured":"Hou Y, Wu R, Zhou Y, et al. Macrophage membrane-coated nanoparticles in inflammatory diseases: from bioinspired design to translational potential. J Nanobiotechnol. 2025;24(1):37.","journal-title":"J Nanobiotechnol"},{"issue":"33","key":"4749_CR47","doi-asserted-by":"publisher","first-page":"22275","DOI":"10.1021\/acsnano.4c06286","volume":"18","author":"ME Zamora","year":"2024","unstructured":"Zamora ME, Essien EO, Bhamidipati K, et al. Marginated neutrophils in the lungs effectively compete for nanoparticles targeted to the endothelium, serving as a part of the reticuloendothelial system. ACS Nano. 2024;18(33):22275\u201397.","journal-title":"ACS Nano"},{"key":"4749_CR48","doi-asserted-by":"publisher","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna C, Mengru H, Lei W, et al. Macrophage M1\/M2 polarization. Eur J Pharmacol. 2020;877:173090.","journal-title":"Eur J Pharmacol"},{"key":"4749_CR49","doi-asserted-by":"publisher","first-page":"1352946","DOI":"10.3389\/fimmu.2024.1352946","volume":"15","author":"M Luo","year":"2024","unstructured":"Luo M, Zhao F, Cheng H, et al. Macrophage polarization: an important role in inflammatory diseases. Front Immunol. 2024;15:1352946.","journal-title":"Front Immunol"},{"key":"4749_CR50","doi-asserted-by":"publisher","first-page":"103961","DOI":"10.1016\/j.resp.2022.103961","volume":"306","author":"J Li","year":"2022","unstructured":"Li J, Chen M, Lu L, Wang J, Tan L. Branched-chain amino acid transaminase 1 inhibition attenuates childhood asthma in mice by effecting airway remodeling and autophagy. Respir Physiol Neurobiol. 2022;306:103961.","journal-title":"Respir Physiol Neurobiol"},{"key":"4749_CR51","doi-asserted-by":"publisher","first-page":"16040","DOI":"10.1038\/ncomms16040","volume":"8","author":"AE Papathanassiu","year":"2017","unstructured":"Papathanassiu AE, Ko JH, Imprialou M, et al. BCAT1 controls metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases. Nat Commun. 2017;8:16040.","journal-title":"Nat Commun"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04749-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04749-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04749-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:21:46Z","timestamp":1790551306000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04749-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4749"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04749-9","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"26 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures and protocols were conducted in accordance with the ARRIVE guidelines and were approved by the Animal Ethical and Experimental Committee of the Army Medical University (Chongqing, China) (AMUWEC20245295). All methods were performed in compliance with relevant institutional and national guidelines for the care and use of laboratory animals.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"909"}}